Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-026200

Chief Operating Officer sold 3,586 shares at $42.34 ($151,831)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK Chief Operating Officer 2021-04-07 Sale −3,586 $42.34 $151,831 67,018 D: show line 1 in the form
Open-market sales · 3,586 sh · avg $42.34 · $151,831
Loading xslF345X03/doc4.xml…